Correction: Effect of preexisting human leukocyte antigen donor-specific antibodies especially human leukocyte antigen-DQ on kidney transplant outcome

A correction has been made to Section: Methodology, 2.4 Study Procedure, 1:

“All recipients underwent panel reactive antibody (PRA) screening and single antigen bead (SAB) assay using the LIFECODES^® Single Antigen Assays (LSA) by Immucor- Werfen to detect IgG class I and class II anti-HLA antibodies, including anti-HLA-DQ”.

A correction has been made to Section: Discussion, 8:

“The application of LIFECODES^® Single Antigen Assays (LSA) with longitudinal MFI assessment serves as a clinically informative method for dynamic stratification of allograft rejection risk”.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Footnotes

Edited and reviewed by: Andrea Angeletti, Giannina Gaslini Institute (IRCCS), Italy